Immunomedics, Inc. (IMMU) said Friday that it has priced its underwritten public offering of about 6.09 million shares of common stock, at a price to the public of $2.30 per share, resulting in gross proceeds of $14.0 million.
The offering is expected to close on or about February 27.
Immunomedics has granted the underwriters a 30 day option to purchase up to 913,044 additional shares of common stock to cover over-allotments, if any.
For comments and feedback: editorial@rttnews.com